-
Je něco špatně v tomto záznamu ?
A multi-country study of prevalence and early childhood mortality among children with omphalocele
WN. Nembhard, JEH. Bergman, MD. Politis, J. Arteaga-Vázquez, E. Bermejo-Sánchez, MA. Canfield, JD. Cragan, S. Dastgiri, HEK. de Walle, ML. Feldkamp, A. Nance, M. Gatt, B. Groisman, P. Hurtado-Villa, K. Kallén, D. Landau, N. Lelong, J....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
037062
Arkansas Biosciences Institute
5U01DD000491
NCBDD CDC HHS - United States
Instituto de Salud Carlos III
AZV 17-29622A
Czech Ministry of Health
CC999999
Intramural CDC HHS - United States
Ministry of Science and Innovation, of Spain
Fundación 1000 sobre Defectos Congénitos, of Spain
Direzione Diritti di cittadinanza e coesione sociale-Regione Toscana
Dutch Ministry of Welfare, Health and Sports
Dutch Ministry of Welfare, Health and Sports.
Public Health Wales
PubMed
33067932
DOI
10.1002/bdr2.1822
Knihovny.cz E-zdroje
- MeSH
- dětská úmrtnost MeSH
- dítě MeSH
- kojenec MeSH
- lidé MeSH
- narození mrtvého plodu MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- prevalence MeSH
- pupeční kýla * epidemiologie MeSH
- retrospektivní studie MeSH
- těhotenství MeSH
- Check Tag
- dítě MeSH
- kojenec MeSH
- lidé MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
BACKGROUND: Omphalocele is the second most common abdominal birth defect and often occurs with other structural and genetic defects. The objective of this study was to determine omphalocele prevalence, time trends, and mortality during early childhood, by geographical region, and the presence of associated anomalies. METHODS: We conducted a retrospective study with 23 birth defect surveillance systems in 18 countries who are members of the International Clearinghouse for Birth Defects Surveillance and Research that submitted data on cases ascertained from 2000 through 2012, approximately 16 million pregnancies were surveyed that resulted in live births, stillbirths, or elective terminations of pregnancy for fetal anomalies (ETOPFA) and cases with omphalocele were included. Overall prevalence and mortality rates for specific ages were calculated (day of birth, neonatal, infant, and early childhood). We used Kaplan-Meier estimates with 95% confidence intervals (CI) to calculate cumulative mortality and joinpoint regression for time trend analyses. RESULTS: The prevalence of omphalocele was 2.6 per 10,000 births (95% CI: 2.5, 2.7) and showed no temporal change from 2000-2012 (average annual percent change = -0.19%, p = .52). The overall mortality rate was 32.1% (95% CI: 30.2, 34.0). Most deaths occurred during the neonatal period and among children with multiple anomalies or syndromic omphalocele. Prevalence and mortality varied by registry type (e.g., hospital- vs. population-based) and inclusion or exclusion of ETOPFA. CONCLUSIONS: The prevalence of omphalocele showed no temporal change from 2000-2012. Approximately one-third of children with omphalocele did not survive early childhood with most deaths occurring in the neonatal period.
Arkansas Reproductive Health Monitoring System Arkansas Children's Hospital Little Rock Arkansas USA
Department of Epidemiology Emory University Rollins School of Public Health Atlanta Georgia USA
Department of Medical Genetics Thomayer Hospital Prague Czech Republic
Department of Neonatology Soroka Medical Center Beer Sheva Israel
ECEMC Instituto de Salud Carlos 3 Madrid Spain
ECLAMC Center for Medical Education and Clinical Research Buenos Aires Argentina
Health Services Management Research Centre Tabriz University of Medical Sciences Tabriz Iran
Human Genetics Institute Pontificia Universidad Javeriana Bogotá Colombia
Malta Congenital Anomalies Registry Directorate for Health Information and Research Valletta Malta
National Board of Health and Welfare Stockholm Sweden
Omni Net for Children International Charitable Fund Rivne Ukraine
Slovak Teratologic Information Centre Slovak Medical University Bratislava Slovakia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026360
- 003
- CZ-PrNML
- 005
- 20211026132949.0
- 007
- ta
- 008
- 211013s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/bdr2.1822 $2 doi
- 035 __
- $a (PubMed)33067932
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Nembhard, Wendy N $u Arkansas Center for Birth Defects Research and Prevention, Fay W. Boozman College of Public Health, Department of Epidemiology, University of Arkansas for Medical Sciences, Little Rock, Little Rock, Arkansas, USA $u Arkansas Reproductive Health Monitoring System, Arkansas Children's Hospital, Little Rock, Arkansas, USA
- 245 12
- $a A multi-country study of prevalence and early childhood mortality among children with omphalocele / $c WN. Nembhard, JEH. Bergman, MD. Politis, J. Arteaga-Vázquez, E. Bermejo-Sánchez, MA. Canfield, JD. Cragan, S. Dastgiri, HEK. de Walle, ML. Feldkamp, A. Nance, M. Gatt, B. Groisman, P. Hurtado-Villa, K. Kallén, D. Landau, N. Lelong, J. Lopez-Camelo, L. Martinez, M. Morgan, A. Pierini, A. Rissmann, A. Šípek, E. Szabova, G. Tagliabue, W. Wertelecki, I. Zarante, MK. Bakker, V. Kancherla, P. Mastroiacovo
- 520 9_
- $a BACKGROUND: Omphalocele is the second most common abdominal birth defect and often occurs with other structural and genetic defects. The objective of this study was to determine omphalocele prevalence, time trends, and mortality during early childhood, by geographical region, and the presence of associated anomalies. METHODS: We conducted a retrospective study with 23 birth defect surveillance systems in 18 countries who are members of the International Clearinghouse for Birth Defects Surveillance and Research that submitted data on cases ascertained from 2000 through 2012, approximately 16 million pregnancies were surveyed that resulted in live births, stillbirths, or elective terminations of pregnancy for fetal anomalies (ETOPFA) and cases with omphalocele were included. Overall prevalence and mortality rates for specific ages were calculated (day of birth, neonatal, infant, and early childhood). We used Kaplan-Meier estimates with 95% confidence intervals (CI) to calculate cumulative mortality and joinpoint regression for time trend analyses. RESULTS: The prevalence of omphalocele was 2.6 per 10,000 births (95% CI: 2.5, 2.7) and showed no temporal change from 2000-2012 (average annual percent change = -0.19%, p = .52). The overall mortality rate was 32.1% (95% CI: 30.2, 34.0). Most deaths occurred during the neonatal period and among children with multiple anomalies or syndromic omphalocele. Prevalence and mortality varied by registry type (e.g., hospital- vs. population-based) and inclusion or exclusion of ETOPFA. CONCLUSIONS: The prevalence of omphalocele showed no temporal change from 2000-2012. Approximately one-third of children with omphalocele did not survive early childhood with most deaths occurring in the neonatal period.
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a dětská úmrtnost $7 D046688
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a pupeční kýla $x epidemiologie $7 D006554
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a narození mrtvého plodu $7 D050497
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bergman, Jorieke E H $u Department of Genetics, EUROCAT Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
- 700 1_
- $a Politis, Maria D $u Arkansas Center for Birth Defects Research and Prevention, Fay W. Boozman College of Public Health, Department of Epidemiology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
- 700 1_
- $a Arteaga-Vázquez, Jazmín $u RYVEMCE (Mexican Registry and Epidemiological Surveillance of Congenital Malformations), Department of Genetics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
- 700 1_
- $a Bermejo-Sánchez, Eva $u ECEMC (Spanish Collaborative Study of Congenital Malformations) and ECEMC's Clinical Network, Research Unit on Congenital Anomalies, Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, Madrid, Spain
- 700 1_
- $a Canfield, Mark A $u Birth Defects Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, Texas, USA
- 700 1_
- $a Cragan, Janet D $u Metropolitan Atlanta Congenital Defects Program, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
- 700 1_
- $a Dastgiri, Saeed $u Health Services Management Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran
- 700 1_
- $a de Walle, Hermien E K $u Department of Genetics, EUROCAT Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
- 700 1_
- $a Feldkamp, Marcia L $u Division of Medical Genetics, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA
- 700 1_
- $a Nance, Amy $u Utah Birth Defect Network, Bureau of Children with Special Health Care Needs, Division of Family Health and Preparedness, Utah Department of Health, Salt Lake City, Utah, USA
- 700 1_
- $a Gatt, Miriam $u Malta Congenital Anomalies Registry, Directorate for Health Information and Research, Valletta, Malta
- 700 1_
- $a Groisman, Boris $u National Network of Congenital Anomalies of Argentina (RENAC), National Center of Medical Genetics, National Administration of Laboratories and Health Institutes, National Ministry of Health and Social Development, Buenos Aires, Argentina
- 700 1_
- $a Hurtado-Villa, Paula $u Department of Basic Sciences of Health, School of Health, Pontificia Universidad Javeriana Cali, Cali, Colombia
- 700 1_
- $a Kallén, Kärin $u National Board of Health and Welfare, Stockholm, Sweden
- 700 1_
- $a Landau, Danielle $u Department of Neonatology, Soroka Medical Center, Beer-Sheva, Israel
- 700 1_
- $a Lelong, Nathalie $u REMAPAR, Paris Registry of Congenital Malformations, Inserm UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in Pregnancy, Paris Descartes University, Paris, France
- 700 1_
- $a Lopez-Camelo, Jorge $u ECLAMC, Center for Medical Education and Clinical Research (CEMIC-CONICET), Buenos Aires, Argentina
- 700 1_
- $a Martinez, Laura $u Genetics Department, Hospital Universitario Dr Jose E. Gonzalez, Universidad Autonóma de Nuevo León, Nuevo León, Mexico
- 700 1_
- $a Morgan, Margery $u The Congenital Anomaly Register and Information Service for Wales, Singleton Hospital, Swansea, Wales, UK
- 700 1_
- $a Pierini, Anna $u Institute of Clinical Physiology, National Research Council/Fondazione Toscana Gabriele Monasterio, Tuscany Registry of Congenital Defects, Pisa, Italy
- 700 1_
- $a Rissmann, Anke $u Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany
- 700 1_
- $a Šípek, Antonin $u Department of Medical Genetics, Thomayer Hospital, Prague, Czech Republic
- 700 1_
- $a Szabova, Elena $u Slovak Teratologic Information Centre (FPH), Slovak Medical University, Bratislava, Slovakia
- 700 1_
- $a Tagliabue, Giovanna $u Lombardy Congenital Anomalies Registry, Cancer Registry Unit, Fondazione IRCCS, Istituto Nazionale dei tumori, Milan, Italy
- 700 1_
- $a Wertelecki, Wladimir $u Omni-Net for Children International Charitable Fund, Rivne, Ukraine
- 700 1_
- $a Zarante, Ignacio $u Human Genetics Institute, Pontificia Universidad Javeriana, Bogotá, Colombia
- 700 1_
- $a Bakker, Marian K $u Department of Genetics, EUROCAT Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
- 700 1_
- $a Kancherla, Vijaya $u Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA
- 700 1_
- $a Mastroiacovo, Pierpaolo $u International Center on Birth Defects, International Clearinghouse for Birth Defects Surveillance and Research, Rome, Italy
- 773 0_
- $w MED00208301 $t Birth defects research $x 2472-1727 $g Roč. 112, č. 20 (2020), s. 1787-1801
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33067932 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026132955 $b ABA008
- 999 __
- $a ok $b bmc $g 1715162 $s 1146867
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 112 $c 20 $d 1787-1801 $e 20201017 $i 2472-1727 $m Birth defects research $n Birth Defects Res $x MED00208301
- GRA __
- $a 037062 $p Arkansas Biosciences Institute
- GRA __
- $a 5U01DD000491 $p NCBDD CDC HHS $2 United States
- GRA __
- $p Instituto de Salud Carlos III
- GRA __
- $a AZV 17-29622A $p Czech Ministry of Health
- GRA __
- $a CC999999 $p Intramural CDC HHS $2 United States
- GRA __
- $p Ministry of Science and Innovation, of Spain
- GRA __
- $p Fundación 1000 sobre Defectos Congénitos, of Spain
- GRA __
- $p Direzione Diritti di cittadinanza e coesione sociale-Regione Toscana
- GRA __
- $p Dutch Ministry of Welfare, Health and Sports
- GRA __
- $p Dutch Ministry of Welfare, Health and Sports.
- GRA __
- $p Public Health Wales
- LZP __
- $a Pubmed-20211013
